Previously Funded Research

Funding Research to Find a Cure

Kaleidoscope of Hope Foundation has been raising money since 2000 to fund research and help to find a cure for ovarian cancer. Here is some of the previously funded research.

• $100,000+ was awarded to Dr. David Fishman at the National Ovarian Early Detection Program. The program was initially operated at the Northwestern University, but later moved to New York University.
  
  
•  $260,000 was awarded to The Cancer Institute of New Jersey  to fund the four-year  Kaleidoscope of Hope Fellowship  KOH funds supported  a post-doctoral fellow to conduct research and clinical work in an effort to expand the number of board-certified gynecologic oncologists. The grant was presented to Ami P Vaidya, MD.
  
  
• $58,300 was awarded to Fox Chase Cancer Center in Philadelphia to fund epigenetic research for the early detection, predictive classification, and treatment of ovarian cancer. Fox Chase is one of five Specialized Programs of Research Excellence (SPORE) in ovarian cancer in the United States. Paul Cairns, PhD, Member with Tenure, is working on a test for early detection and is researching how to “switch the good genes that suppress tumors back on,” enhancing the effectiveness of low-dose chemotherapy.
  
  
• $79,900 was awarded to Selvendiran Karuppaiyah, PhD, a Research Scientist at Davis Heart & Lung Research Institute at The Ohio State University. The grant funded research in antitumor therapeutics for ovarian cancer.  Mr. Karuppaiyah studied a compound that inhibits the growth and proliferation of cisplatin-resistant human ovarian cancer cells and induces a significant increase in PTEN expression, a gene that suppresses tumors.
  
  
• $10,000 was awarded to the Ovarian Cancer Research Fund (OCRF) for the organization’s outreach and awareness programs.